MedPath

Does Prehabilitation Improve Outcome in Coloncancer Surgery?

Not Applicable
Not yet recruiting
Conditions
Surgery--Complications
Interventions
Other: Prehabilitation and Immunonutrition
Other: Standard Care Arm
Registration Number
NCT04199208
Lead Sponsor
Region Skane
Brief Summary

The study aims to find out if complications after surgery for large bowel (colon) cancer can be reduced or avoided in the most frail and elderly by letting them go through an exercise- and diet regime prior to the surgical procedure.

Detailed Description

All patients with colon cancer who are intended for curative surgery without neoadjuvant chemotherapy who are \>=60 years old will be screened with an ergospirometry. The ones that have a ventilate anaerobic threshold (VAT) of less than 11 mg/ml/kg will be included in the study as they are considered extra frail and have a previously proven high risk for complications. These patients will be randomized to standard care or an intervention of prehabilitation consisting of immunonutrition (protein supplement, multivitamin supplement, Selene etc) and an exercise regimen with 4x1 hours per week of cycling on an ergometer. The exercise regimen will be performed in a group of patients and will be led by a physical therapist to ensure compliance. The resistance of the ergometer will be standardized according to the patient's VAT.

The primary outcome measures will be number of and severity of postoperative complications. Secondary outcome measures include quality of life during prehabilitation with repeated measurements during 5 years after surgery, disease-free survival and overall survival.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria
  • 60 years of older
  • Colon cancer diagnosis (macroscopic, microscopic or x-ray diagnosed)
  • Ventilatory Anaerobic Threshold <11mg/ml/kg
  • Planned open or laparoscopic colectomy due to colon cancer
Exclusion Criteria
  • Lower extremity amputee
  • Disease requiring radio- and/or chemotherapy prior to surgery/palliative disease
  • Distal metastases (Locoregional lymph nodes are OK)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interventional ArmPrehabilitation and ImmunonutritionIntervention of prehabilitation and immunonutrition is given prior to surgery
Standard Care ArmStandard Care ArmStandard perioperative care is given.
Primary Outcome Measures
NameTimeMethod
ComplicationsAssessed at postoperative day 5.

Number of complication(s) according to POMS

Secondary Outcome Measures
NameTimeMethod
Quality of life with SF-36At point in time when patient is informed of the cancer, after prehabilitation (just before surgery), 30 days, 2, 3 and 6 months, 1, 3 and 5 years after surgery.

Quality of life

Disease-free survival30 and 90 days after surgery, 1, 3 and 5 years after surgery.

Cancer-free survival Cancer-free survival of the group of the group

Overall survival30 and 90 days after surgery, 1, 3 and 5 years after surgery.

Overall survival of the group (taking all causes of death into account)

© Copyright 2025. All Rights Reserved by MedPath